ACARIZAX is an innovative allergen extract used as a sublingual immunotherapy treatment designed to alleviate symptoms associated with certain allergies. Specifically, it targets allergies caused by house dust mites, a common trigger for allergic rhinitis and allergic asthma. By administering small, gradually increasing doses of the allergen directly under the tongue, ACARIZAX aims to enhance the immune system's tolerance to house dust mites, thereby reducing the severity of allergic reactions over time. This form of treatment is particularly appealing for its convenience, as it can be taken at home without the need for frequent visits to a healthcare provider. ACARIZAX represents a significant advancement in the management of dust mite allergies, offering a promising option for patients seeking long-term relief from their symptoms.